Dr. Hirsch on Importance of Molecular Testing in Lung Cancer

Fred R. Hirsch, MD, PhD, professor of Medicine, University of Colorado Denver, CEO, the International Association for the Study of Lung Cancer, discusses the importance of molecular testing for patients with lung cancer.

Molecular testing in lung cancer is crucial, Hirsch explains. With the development of personalized medicine, it is important to map a tumor's molecular characteristics, as this has significant clinical implications for many patients. This continues to be an evolving field, he adds.

Over recent years, a collaboration between three organizations has led to the development of a set of evidence-based guidelines for molecular testing.

<<<

View more from the 2016 International Lung Cancer Congress